Effects of BNT162b2 mRNA vaccine on Covid-19 infection and hospitalisation among older people: matched case control study for England
View ORCID ProfileThomas Mason, View ORCID ProfileMatt Whitston, View ORCID ProfileJack Hodgson, View ORCID ProfileRuth E Watkinson, View ORCID ProfileYiu-Shing Lau, View ORCID ProfileOmnia Abdulrazeg, View ORCID ProfileMatt Sutton
doi: https://doi.org/10.1101/2021.04.19.21255461
Thomas Mason
1Performance Analysis Team, NHS England & NHS Improvement, Quarry House, Leeds, UK
Roles: Head of Activity Analysis
Matt Whitston
1Performance Analysis Team, NHS England & NHS Improvement, Quarry House, Leeds, UK
Roles: Senior Analytical Manager
Jack Hodgson
1Performance Analysis Team, NHS England & NHS Improvement, Quarry House, Leeds, UK
Roles: Analytical Officer
Ruth E Watkinson
2Health Organisation, Policy & Economics, School of Health Sciences, University of Manchester, UK
Roles: Research Associate
Yiu-Shing Lau
2Health Organisation, Policy & Economics, School of Health Sciences, University of Manchester, UK
Roles: Research Fellow
Omnia Abdulrazeg
1Performance Analysis Team, NHS England & NHS Improvement, Quarry House, Leeds, UK
Roles: Senior Analytical Manager
Matt Sutton
2Health Organisation, Policy & Economics, School of Health Sciences, University of Manchester, UK
Roles: Professor
Data Availability
Data used in the study are not publicly available and may be obtained via NHS Digital (https://digital.nhs.uk/services/data-access-request-service-dars). The analysis scripts used for the evaluation are available at https://github.com/NHSEI-Analytics/nhs_covid19_effectiveness.
https://github.com/NHSEI-Analytics/nhs_covid19_effectiveness
Posted April 22, 2021.
Effects of BNT162b2 mRNA vaccine on Covid-19 infection and hospitalisation among older people: matched case control study for England
Thomas Mason, Matt Whitston, Jack Hodgson, Ruth E Watkinson, Yiu-Shing Lau, Omnia Abdulrazeg, Matt Sutton
medRxiv 2021.04.19.21255461; doi: https://doi.org/10.1101/2021.04.19.21255461
Effects of BNT162b2 mRNA vaccine on Covid-19 infection and hospitalisation among older people: matched case control study for England
Thomas Mason, Matt Whitston, Jack Hodgson, Ruth E Watkinson, Yiu-Shing Lau, Omnia Abdulrazeg, Matt Sutton
medRxiv 2021.04.19.21255461; doi: https://doi.org/10.1101/2021.04.19.21255461
Subject Area
Subject Areas
- Addiction Medicine (373)
- Allergy and Immunology (690)
- Anesthesia (184)
- Cardiovascular Medicine (2760)
- Dermatology (236)
- Emergency Medicine (414)
- Epidemiology (12413)
- Forensic Medicine (10)
- Gastroenterology (784)
- Genetic and Genomic Medicine (4272)
- Geriatric Medicine (396)
- Health Economics (702)
- Health Informatics (2761)
- Health Policy (1021)
- Hematology (370)
- HIV/AIDS (880)
- Medical Education (404)
- Medical Ethics (112)
- Nephrology (454)
- Neurology (4054)
- Nursing (218)
- Nutrition (600)
- Oncology (2134)
- Ophthalmology (607)
- Orthopedics (251)
- Otolaryngology (313)
- Pain Medicine (256)
- Palliative Medicine (77)
- Pathology (479)
- Pediatrics (1150)
- Primary Care Research (470)
- Public and Global Health (6663)
- Radiology and Imaging (1453)
- Respiratory Medicine (886)
- Rheumatology (422)
- Sports Medicine (353)
- Surgery (465)
- Toxicology (57)
- Transplantation (192)
- Urology (171)